This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Moore E, Devine JW, Trice S, Mistry HH, Potyk R, Nwokeji ED.Cost effectiveness of oral bisphosphonates administered on extended dosing intervals. 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research: 163 abstr. PIH10, 16 May 2009. Available from: URL: http://www3.interscience.wiley.com
Niyazov A, Gricar JA.Comparison of levonorgestrel intrauterine system to oral contraceptives on contraception: a cost-effectiveness analysis. 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research: 163 abstr. PIH8, 16 May 2009. Available from: URL: http://www3.interscience.wiley.com
Mateus C, Wolowacz S, Pereira JA.Cost-effectiveness of dabigatran etexilate for the primary prevention of venous thromboembolism in total hip and knee replacement in Portugal. 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research: 148 abstr. PCV39, 16 May 2009. Available from: URL: http://www3.interscience.wiley.com
Rights and permissions
About this article
Cite this article
Dabigatran etexilate pays off for VTE prophylaxis. Pharmacoecon. Outcomes News 579, 5 (2009). https://doi.org/10.2165/00151234-200905790-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905790-00007